Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Fatima Aerts Kaya"'
Autor:
Özgür Dogus Erol, Burcu Pervin, Mehmet Emin Şeker, Burcu Özçimen, Şimal Şenocak, Sema Nur Gür, Hasan Basri Kiliç, Merve Gizer, Petek Korkusuz, Nico Peter van Til, Yusuf Çetin Kocaefe, Fatima Aerts Kaya
Publikováno v:
HemaSphere, Vol 7, p e37198af (2023)
Externí odkaz:
https://doaj.org/article/a0c1f33184514a73ad55aa4b5356ba3a
Autor:
Gülen Güney-Esken, Özgür Doğuş Erol, Burcu Pervin, Gülben Gürhan Sevinç, Tamer Önder, Elif Bilgiç, Petek Korkusuz, Ayşen Günel-Özcan, Duygu Uçkan-Çetinkaya, Fatima Aerts-Kaya
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of f
Externí odkaz:
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
Trakya University Journal of Natural Sciences, Vol 20, Pp 17-32 (2019)
Stem cell therapy offers a great advantage for the development of new treatments in the field of regenerative and restorative medicine. However, the use of stem cell therapies and their clinical indications can even be further improved using genetic
Externí odkaz:
https://doaj.org/article/0ec320dc592d48feb65de1b7cd4b03fb
Publikováno v:
World Journal of Stem Cells
Despite a vast amount of different methods, protocols and cryoprotective agents (CPA), stem cells are often frozen using standard protocols that have been optimized for use with cell lines, rather than with stem cells. Relatively few comparative stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8817137fcdab29e57b7af38326a1525
http://europepmc.org/articles/PMC8474714
http://europepmc.org/articles/PMC8474714
Autor:
Gülben Gürhan Sevinç, Elif Bilgiç, Özgür Doğuş Erol, Fatima Aerts-Kaya, Aysen Gunel-Ozcan, Tamer T. Onder, Duygu Uckan-Cetinkaya, Burcu Pervin, Petek Korkusuz, Gülen Güney-Esken
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background: Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b4da836eb8f9bd97526e935d04be45
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
Biotechnic & Histochemistry. 97:79-89
Multipotent mesenchymal stromal cells (MSC) can be isolated from many tissues, including bone marrow (BM) and placenta (PL). Human placenta can be obtained readily without invasive procedures. There may be differences, however, in differentiation cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7487cfa5a534dff42bef2a2c2393523
https://doi.org/10.1080/10520295.2021.1885739
https://doi.org/10.1080/10520295.2021.1885739
Publikováno v:
International Journal of Hematology. 113:5-9
In recent years, multipotent mesenchymal stromal cells (MSCs) have demonstrated tremendous potential for use in regenerative medicine. CXCR4, the receptor for CXCL12, is highly expressed by bone marrow (BM) MSCs and the CXCR4/CXCL12 axis has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9d3be098565296204082c08633d228
https://doi.org/10.1007/s12185-020-03043-0
https://doi.org/10.1007/s12185-020-03043-0
Autor:
Özgür Özyüncü, F. Duygu Uçkan-Çetinkaya, Aynura Mammadova, Fatima Aerts-Kaya, Gerard Wagemaker, Trudi P. Visser, Burcu Pervin
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:634-642
The newly developed 6-hydroxychromanol derivate SUL-109 was shown to provide protection during hypothermic storage of several cell lines, but has not been evaluated in hematopoietic stem cells (HSCs). Hypothermic preservation of HSCs would be preferr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635be5b890ea6f067a0c8f5e94728169
https://doi.org/10.1016/j.bbmt.2019.12.770
https://doi.org/10.1016/j.bbmt.2019.12.770
Autor:
Melike Tombaz, Aysen Gunel-Ozcan, Duygu Uckan-Cetinkaya, Mustafa Keles, Ozge Burcu Sahan, Ilgin Cagnan, Ozlen Konu, Ayse Gokce Keskus, Fatima Aerts-Kaya
Publikováno v:
Human Cell
Fanconi anemia (FA) is a rare genetic disorder characterized by genomic instability, developmental defects, and bone marrow (BM) failure. Hematopoietic stem cells (HSCs) in BM interact with the mesenchymal stem/stromal cells (MSCs); and this partly s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425286650764373703b216635063491a
https://aperta.ulakbim.gov.tr/record/238442
https://aperta.ulakbim.gov.tr/record/238442
Autor:
Gülen, Güney-Esken, Fatima, Aerts-Kaya
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2549
Here, we describe a protocol for reprogramming of bone marrow-derived multipotent mesenchymal stromal/stem cells to obtain induced pluripotent stem cells from patients with primary immune deficiencies using lentiviral vectors, followed by hematopoiet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc29734dbdc96f3a84d7f39aad35a828
https://pubmed.ncbi.nlm.nih.gov/34907509
https://pubmed.ncbi.nlm.nih.gov/34907509